New Publication from DC CFAR Investigators, Sarah Calabrese, PhD and Tamara Taggart, PhD

Drs. Sarah Calabrese and Tamara Taggart Photo
May 15, 2019
The article discusses a study that examined the current CDC clinical guidelines for HIV pre-exposure prophylaxis (PrEP), which are used to assess a patient's PrEP eligibility. In particular, the researchers looked at how two versions of PrEP eligibility criteria within the guidelines - guidance summary criteria and recommended indications criteria -  could potentially effect the eligibility of heterosexually active women to receive PrEP, as both criteria require women's knowledge of their own risk behavior, but the recommended indications  also require women's knowledge of their partners' HIV risk. The authors found that the current guidelines disqualify many women who could benefit from PrEP and recommend reforms to improve clarity.
Click here to read the full article.